Strand Displacement Amplification Market Size (2024 - 2029)

The strand displacement amplification market is projected to experience growth driven by the increasing prevalence of chronic and infectious diseases, which boosts the demand for testing solutions. The market's expansion is further supported by the rising adoption of point-of-care testing, offering immediate results and enhancing testing accessibility. Despite these growth drivers, challenges such as procedural disadvantages and the presence of alternative testing methods may impede market expansion.

Home Market Analysis Healthcare Research Device Drug Combination Research Co-Packages Research Therapeutic Products Research Medical Cements Research Strand Displacement Amplification Market Market Size

Market Size of Strand Displacement Amplification Industry

Strand Displacement Amplification Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 5.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Strand Displacement Amplification Market Major Players

*Disclaimer: Major Players sorted in no particular order

Strand Displacement Amplification Market Analysis

The strand displacement amplification market is anticipated to register a CAGR of nearly 5.2% during the forecast period.

  • The impact of COVID-19 on the studied market was significant as several strand displacement amplification-based products were developed to detect COVID-19. For instance, according to the study published in Nature Communications in August 2021, a non-enzymatic isothermal strand displacement and amplification (NISDA) was developed to detect SARS-CoV-2 RNA. 
  • A study was conducted to test its efficacy, and it was seen that in 164 clinical oropharyngeal RNA samples, the NISDA assay was 100 % specific, and it was 96.77% and 100% sensitive when used in the laboratory and hospital, respectively. Thus, the COVID-19 pandemic impacted the market significantly, as strand displacement amplification tests were developed to detect COVID-19. However, as the pandemic subsided, the studied market is expected to have normal growth during the forecast period of the study.
  • Factors that are driving the market growth include increasing prevalence and incidence of infectious diseases such as tuberculosis and hepatitis, among others. Other factors that are driving the market growth include the rising prevalence of chronic diseases and the growing adoption of point-of-care testing.
  • The rising prevalence of chronic and infectious diseases around the world is one of the major factors driving the market growth, as it will lead to the usage of more strand displacement amplification tests. For instance, according to the data published by the World Health Organization (WHO) in September 2022, a total of 348.9 thousand specimens were processed in China for influenza testing, out of which 49,260 cases were found to be positive. The source also stated that 211.6 thousand specimens were tested in Australia for influenza, out of which 11,311 cases turned out to be positive. Thus, the high prevalence of such infectious diseases is expected to boost the adoption of strand displacement amplification tests.
  • Moreover, according to an article published by the WHO in 2022, an estimated 10.6 million around the world people fell ill with tuberculosis in 2021, which showed an increase of 4.5% from 10.1 million in the previous year. The source also stated that China accounted for 7.4% of tuberculosis cases around the world in 2021, which is the third highest. 
  • China is also considered a high-burden country for tuberculosis (TB), Human Immunodeficiency Virus (HIV) related TB, and Multidrug-resistant tuberculosis /rifampicin-resistant (MDR/RR-TB) from 2021 to 2025. Thus, the high prevalence of tuberculosis around the world is also expected to boost market growth.
  • Additionally, the increasing demand for point-of-care testing is also expected to boost market growth, as it will lead to the increased usage of strand displacement amplification products. For instance, according to an article published by PubMed in March 2022, point-of-care testing (POCT) has been gaining attention as a tool that can provide immediate test results, and its adoption is increasing around the world.
  • Hence, the factors above, such as the rising prevalence of chronic and infectious diseases and the growing adoption of point-of-care testing, are expected to enhance market growth. However, the disadvantages associated with the procedure and the availability of alternative procedures are expected to hinder market growth.

Strand Displacement Amplification Industry Segmentation

As per the scope of the report, strand displacement amplification (SDA) is isothermal, in vitro nucleic acid amplification technique that occurs at a constant temperature. SDA is often used for the detection of pathogens and diagnosis of chronic diseases. 

The strand displacement amplification market is segmented by application (tuberculosis, hepatitis, malaria, influenza, cancer, and others), end-user (hospitals, diagnostic laboratories, and others), and geography (North America, Europe, Asia-Pacific, and the Rest of the World). 

The report offers the value (in USD million) for the above segments.

By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Other Applications
By End-User
Hospitals
Diagnostic laboratories
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Need A Different Region Or Segment?
Customize Now

Strand Displacement Amplification Market Size Summary

The strand displacement amplification market is poised for steady growth, driven by the increasing prevalence of infectious and chronic diseases, alongside the rising adoption of point-of-care testing. The market experienced a significant impact due to the COVID-19 pandemic, which spurred the development of strand displacement amplification-based products for virus detection. As the pandemic's effects wane, the market is expected to return to normal growth trajectories. The demand for these tests is further bolstered by the high incidence of diseases such as tuberculosis and hepatitis, as well as the growing need for rapid diagnostic solutions. The market's expansion is also supported by advancements in cancer diagnostics, where strand displacement amplification techniques are being utilized to identify biomarkers, enhancing early detection and treatment outcomes.

Regionally, North America is anticipated to maintain a substantial market share, attributed to the increasing burden of chronic diseases and a growing elderly population. The presence of key market players in this region further strengthens its market position. The demand for strand displacement amplification tests is expected to rise due to the prevalence of infectious diseases like HIV and hepatitis C, as well as the increasing incidence of cancer. The competitive landscape of the market is moderately active, with several prominent players such as Bio-Rad Laboratories, Inc., G Biosciences, and New England Biolabs driving innovation and expansion. Recent strategic moves, such as acquisitions and regulatory submissions, highlight the ongoing efforts to enhance the accessibility and efficiency of diagnostic solutions utilizing strand displacement amplification technology.

Explore More

Strand Displacement Amplification Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence and Incidence of Infectious and Chronic Diseases

      2. 1.2.2 Growing Adoption of Point-of-Care Testing

    3. 1.3 Market Restraints

      1. 1.3.1 Disadvantages Associated with the Procedure

      2. 1.3.2 Availability of Alternative Techniques

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Application

      1. 2.1.1 Tuberculosis

      2. 2.1.2 Hepatitis

      3. 2.1.3 Malaria

      4. 2.1.4 Influenza

      5. 2.1.5 Cancer

      6. 2.1.6 Other Applications

    2. 2.2 By End-User

      1. 2.2.1 Hospitals

      2. 2.2.2 Diagnostic laboratories

      3. 2.2.3 Other End-Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Rest of the World

Strand Displacement Amplification Market Size FAQs

The Strand Displacement Amplification Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)

New England Biolabs , Nippon Genetics .Co .Ltd , G Biosciences , Bio-Rad Laboratories, Inc. and Lucigen are the major companies operating in the Strand Displacement Amplification Market.

Strand Displacement Amplification Report Snapshots

Strand Displacement Amplification Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)